GGrantIndex
← Leaderboards

Natalia Aleksandr Osna

University Of Nebraska Medical Center

Google Scholar ↗PubMed ↗ORCID ↗
$4,604,885
Attributed
$8,021,077
Total exposure
9
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,021,077 · 8
VA$0 · 1

By mechanism

R01$6,221,432 · 3
R21$1,074,356 · 3
P50$725,289 · 2
I01$0 · 1

Top collaborators

Most similar at University Of Nebraska Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Liver”

Research focus

LiverHepatocyteAlcoholsAffectCellsEthanolClinical TrialsLiver DiseasesIn VivoViralMediatingPathogenesisLiver InjuryInfectionAlcohol EffectAlcohol ConsumptionAlcohol AbuseMacrophagePathologyModalityPreventCessation Of LifeLiver FibrosisMortality

Grant awards (25)

New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B$611,174
R01 · FY2025 · AI · contact PI
Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice$365,775
R01 · FY2025 · DK
Alcohol Promotes Hepatitis B Progression by Impairment of Innate Immunity in Liver Cells$241,763
P50 · FY2025 · AA · contact PI
Non-ISGylated HIV proteins are sorted to hepatic exosomes to activate liver fibrosi$182,281
R21 · FY2025 · AA · contact PI
New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B$611,174
R01 · FY2024 · AI
Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice$390,632
R01 · FY2024 · DK
Alcohol Promotes Hepatitis B Progression by Impairment of Innate Immunity in Liver Cells$241,763
P50 · FY2024 · AA · contact PI
Non-ISGylated HIV proteins are sorted to hepatic exosomes to activate liver fibrosi$220,656
R21 · FY2024 · AA · contact PI
New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B$611,174
R01 · FY2023 · AI
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$516,042
R01 · FY2023 · AA · contact PI
Development and Preclinical Evaluation of Nanoformulations in Liver Fibrotic Mice$420,765
R01 · FY2023 · DK
Alcohol Promotes Hepatitis B Progression by Impairment of Innate Immunity in Liver Cells$241,763
P50 · FY2023 · AA · contact PI
New generation of long acting nucleos(t)ides and immune stimulant for treatment of chronic hepatitis B$610,511
R01 · FY2022 · AI
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$513,541
R01 · FY2022 · AA · contact PI
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$525,723
R01 · FY2021 · AA · contact PI
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$515,878
R01 · FY2020 · AA
Extracellular vesicles as the vehicles for promoting liver injury induced by HIV and alcohol$529,043
R01 · FY2019 · AA
Ethanol-Induced Hypomethylation Accelerates Hepatitis C Progression$0
I01 · FY2016 · VA · contact PI
Ethanol-Induced Hypomethylation Accelerates Hepatitis C Progression$0
I01 · FY2015 · VA · contact PI
Ethanol-Induced Hypomethylation Accelerates Hepatitis C Progression$0
I01 · FY2014 · VA · contact PI
Ethanol-Induced Hypomethylation Accelerates Hepatitis C Progression$0
I01 · FY2013 · VA · contact PI
Effects of Ethanol on Proteasome-HCV Core Protein Interactions$155,925
R21 · FY2010 · AA · contact PI
Effects of Ethanol on Proteasome-HCV Core Protein Interactions$189,000
R21 · FY2009 · AA · contact PI
Ethanol Effects on Antigen Presentation in Liver Cells$176,869
R21 · FY2006 · AA · contact PI
Ethanol Effects on Antigen Presentation in Liver Cells$149,625
R21 · FY2005 · AA